Corindus, a Siemens Healthineers company, announced today the opening of its new headquarters at 275 Grove Street in Newton, USA. Siemens Healthineers relocated the Corindus headquarters from its previous location in Waltham, USA to accommodate company growth, doubling the size of the current location from 35,000 to 77,000 square feet, according to a company press release.
The headquarters will serve as the global ‘Centre for Excellence’ for Siemens Healthineers’ endovascular robotic technologies—encompassing development, manufacturing, and administration, the release adds.
“Our new facility is a testament to the commitment Siemens Healthineers has made to metro Boston and Massachusetts as a hub for innovative talent,” said Wayne Markowitz, executive vice president and head of Corindus. “As we continue to advance our robotic-assisted platform, the new facility will support our mission to elevate the standard of care and increase access to cutting-edge treatment for coronary artery and neurovascular disease.”
The new facility marks the first of 15 new offices or major facility expansions that Siemens Healthineers has planned in the USA. It also features a fully equipped ‘Customer Experience Centre’ that simulates the robotic setup in a hospital cath lab and control room that will include remote capabilities over various types of connections, according to the release.
In addition, the new office will provide physicians and cath lab personnel the opportunity to participate in interactive demonstrations of the CorPath GRX system—which the company claims is the first US Food and Drug Administration (FDA)-cleared medical device to bring robotic precision to percutaneous coronary and vascular procedures, and the only CE-marked robotic system for neurovascular use in select markets—and future innovations.
“Siemens Healthineers is an important addition to the Newton community’s growing roster of innovative companies,” said Massachusetts 4th Congressional District Representative Jake Auchincloss. “I am honoured to welcome a leader in the endovascular robotics space and look forward to the company’s continued growth and leadership as a top employer in the area.”